ClinVar Miner

Submissions for variant NM_003172.4(SURF1):c.54+10G>A

gnomAD frequency: 0.00276  dbSNP: rs587598397
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000128346 SCV000171939 benign not specified 2014-04-01 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Illumina Laboratory Services, Illumina RCV000329138 SCV000478295 uncertain significance Leigh syndrome 2016-06-14 criteria provided, single submitter clinical testing
Invitae RCV000329138 SCV000627067 benign Leigh syndrome 2024-01-31 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000676736 SCV001472706 likely benign not provided 2021-10-21 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000676736 SCV004156708 likely benign not provided 2024-02-01 criteria provided, single submitter clinical testing SURF1: BS2
Mayo Clinic Laboratories, Mayo Clinic RCV000676736 SCV000802537 likely benign not provided 2016-03-02 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.